Specialized Expertise IHMA offers comprehensive services across all stages of antimicrobial drug development, making it an ideal partner for pharmaceutical and biotech companies seeking expert support in clinical trials, regulatory approval, and commercialization processes.

Global Presence With laboratories in both the US and Europe and active participation in industry events like the ESCMID Global Congress, IHMA demonstrates a strong international footprint, providing opportunities for partnerships and collaborations across diverse markets.

Technological Edge Utilizing state-of-the-art technology such as advanced testing methods and data analytics, IHMA can address stringent testing requirements, presenting a compelling case for buyers demanding high-quality, reliable antimicrobial research services.

Financial Capacity With revenue estimates between $50M and $100M, IHMA has significant financial resources, enabling it to invest in expanding its capabilities, adopt new technologies, and potentially enter co-development agreements with innovative partners.

Industry Engagement Active participation in global industry events indicates IHMA’s commitment to staying at the forefront of antimicrobial research trends, creating opportunities for sales teams to connect with decision-makers involved in cutting-edge drug development initiatives.